RSS Feeds
Pituitary Adenomas
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
The article by Kupersmith and colleagues [1] does not mention the findings from magnetic resonance imaging and computed tomography scans in their patients with macroadenoma of the pituitary gland and visual field defects. A hemorrhagic pituitary adenoma during pregnancy may cause an acute increase in the size of the macroadenoma and may cause visual field defects. On the basis of magnetic resonance imaging scans, such pituitary “apoplexy” has been classified as classical, subacute, and asymptomatic [2]. Further, the density of the pituitary adenoma may give an idea of the acuteness of the apoplexy and help distinguish a neoplastic process from a non-neoplastic process [2, 3].
Why did none of the 6 of 8 patients with pituitary macroadenoma who had documented visual field defects have surgical intervention during their pregnancy? Trans-sphenoidal surgical resection of pituitary adenomas during pregnancy is a safe procedure and is the treatment of choice in patients with visual field involvement [4, 5].
Mumtaz A. Siddiqui
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
- Copyright ©2004 by the American College of Physicians
